Lack of alpha-synuclein does not alter apoptosis of neonatal catecholaminergic neurons.

about

Cell death pathways in Parkinson's disease: proximal triggers, distal effectors, and final steps.α-Synuclein in Parkinson's disease.A novel cell death pathway that is partially caspase dependent, but morphologically non-apoptotic, elicited by proteasomal inhibition of rat sympathetic neurons.

P2860

Q37376117-A822179B-27C3-4ACF-BEC4-CEBF90BD34D8 Q37987146-3AD95E1A-2911-40CB-AA4E-E876A887463B Q46808939-F785B9EE-B08B-452D-8041-90920DA07404

P2860

Lack of alpha-synuclein does not alter apoptosis of neonatal catecholaminergic neurons.

Item

http://www.wikidata.org/entity/Q42426462

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Lack of alpha-synuclein does not alter apoptosis of neonatal catecholaminergic neurons.

@en

Lack of alpha-synuclein does not alter apoptosis of neonatal catecholaminergic neurons.

@nl

type

Item

label

Lack of alpha-synuclein does not alter apoptosis of neonatal catecholaminergic neurons.

@en

Lack of alpha-synuclein does not alter apoptosis of neonatal catecholaminergic neurons.

@nl

prefLabel

Lack of alpha-synuclein does not alter apoptosis of neonatal catecholaminergic neurons.

@en

Lack of alpha-synuclein does not alter apoptosis of neonatal catecholaminergic neurons.

@nl

P1476

Lack of alpha-synuclein does not alter apoptosis of neonatal catecholaminergic neurons

@en

P2093

Isabelle Lang-Rollin

http://www.w3.org/2001/XMLSchema#string

Leonidas Stefanis

http://www.w3.org/2001/XMLSchema#string

Qiaohong Wang

http://www.w3.org/2001/XMLSchema#string

Tinmarla Oo

http://www.w3.org/2001/XMLSchema#string

P2860

Wild-type but not Parkinson's disease-related ala-53 --> Thr mutant alpha -synuclein protects neuronal cells from apoptotic stimuli

Regulation of alpha-synuclein by bFGF in cultured ventral midbrain dopaminergic neurons

Inhibition of fibrillization and accumulation of prefibrillar oligomers in mixtures of human and mouse alpha-synuclein

Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system

Effect of the overexpression of wild-type or mutant alpha-synuclein on cell susceptibility to insult.

alpha-Synuclein protects against oxidative stress via inactivation of the c-Jun N-terminal kinase stress-signaling pathway in neuronal cells.

Beta-synuclein displays an antiapoptotic p53-dependent phenotype and protects neurons from 6-hydroxydopamine-induced caspase 3 activation: cross-talk with alpha-synuclein and implication for Parkinson's disease.

Neurobiology of alpha-synuclein.

Resistance of alpha -synuclein null mice to the parkinsonian neurotoxin MPTP.

Regulation of the development of mesencephalic dopaminergic systems by the selective expression of glial cell line-derived neurotrophic factor in their targets.

P304

1969-1972

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1460-9568.2004.03638.X

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Robert E Burke

William T Dauer

P577

2004-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8334935

http://www.w3.org/2001/XMLSchema#string

P698

15380020

http://www.w3.org/2001/XMLSchema#string

Lack of alpha-synuclein does not alter apoptosis of neonatal catecholaminergic neurons.

about

P2860

P2860

Lack of alpha-synuclein does not alter apoptosis of neonatal catecholaminergic neurons.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P5875

P698